1.Research progress on the effectiveness of smallpox vaccination against mpox virus infection.
Yun Shao XU ; Ming Yue JIANG ; Yan Lin CAO ; Yan Xia SUN ; Qiang Ru HUANG ; Wei Zhong YANG ; Lu Zhao FENG
Chinese Journal of Epidemiology 2023;44(4):673-676
With the expansion of mpox virus infection from endemic to a global epidemic in 2022, the WHO declared that the mpox event constituted a Public Health Emergency of International Concern. Due to the high degree of gene sequence similarity among orthopox viruses and cross-reactive antibodies induced by orthoviruses, smallpox vaccination may affect the immune response induced by mpox virus infection. The analysis of the protective effects of smallpox vaccination against mpox virus infection will help define the focus of prevention and control. In this review, we clarify the protection of the smallpox vaccine against mpox virus infection by analyzing the correlation between smallpox vaccination, immune response status, and clinical data and providing evidence for the prevention, control, and strategies of mpox epidemics.
Humans
;
Smallpox/epidemiology*
;
Monkeypox/drug therapy*
;
Smallpox Vaccine/therapeutic use*
;
Vaccination
;
Immunity
3.Estimating the medical capacity required to administer mass prophylaxis: a hypothetical outbreak of smallpox virus infection in Korea
Sangwoo TAK ; Soomin LIM ; Heesu KIM
Epidemiology and Health 2019;41(1):2019044-
OBJECTIVES: The aim of this study was to estimate the medical surge capacity required for mass prophylaxis based on a hypothetical outbreak of smallpox.METHODS: We performed a simulation using the Bioterrorism and Epidemic Outbreak Response Model and varied some important parameters, such as the number of core medical personnel and the number of dispensing clinics.RESULTS: Gaps were identified in the medical surge capacity of the Korean government, especially in the number of medical personnel who could respond to the need for mass prophylaxis against smallpox.CONCLUSIONS: The Korean government will need to train 1,000 or more medical personnel for such an event, and will need to prepare many more dispensing centers than are currently available.
Bioterrorism
;
Korea
;
Smallpox
;
Surge Capacity
;
Vaccination
;
Variola virus
4.Cutaneous Manifestations of Potential Chemical, Biological, and Radiological Agents and Their Clinical Management.
Jun Young LEE ; Byung Sub KIM ; Young Min PARK
Korean Journal of Dermatology 2016;54(9):683-692
The level of terrorist threats using chemical, biological, and radiological agents has been continuously increasing, and it is an undeniable truth that these agents are actually in use today. The fact that most chemical, biological, and radiological agents cause skin-related symptoms, and that the skin symptoms are observed at a relatively early stage of the condition, leads to the conclusion that dermatologists could be the first point of contact for potential victims of these agents. It is highly important that first responders are able to recognize symptoms caused by these agents early and react quickly. Therefore, dermatologists do have a responsibility to take on a role in dealing with chemical, biological, and radiological attacks, and pre-equip themselves with professional knowledge in this field. Among the various types of chemical agents, typical examples of agents causing skin-related symptoms are blistering agents, which lead to bullae and necrosis on the skin. Biological agents are classified from Category A to C according to their respective risk factors. The most dangerous Category A agents include anthrax, smallpox, plague, tularemia, and viral hemorrhagic fever, all of which are known to show characteristic skin-related symptoms. Upon exposure to a certain level of radiation, radiological agents can also lead to erythema on the skin. In this article, we will discuss various characteristics and up-to-date treatment methods of potential chemical, biological, and radiological agents to help dermatologists advance their knowledge in this field.
Anthrax
;
Biological Factors
;
Blister
;
Erythema
;
Hemorrhagic Fevers, Viral
;
Necrosis
;
Plague
;
Risk Factors
;
Skin
;
Smallpox
;
Terrorism
;
Tularemia
;
Weapons
5.Cutaneous Manifestations of Potential Chemical, Biological, and Radiological Agents and Their Clinical Management.
Jun Young LEE ; Byung Sub KIM ; Young Min PARK
Korean Journal of Dermatology 2016;54(9):683-692
The level of terrorist threats using chemical, biological, and radiological agents has been continuously increasing, and it is an undeniable truth that these agents are actually in use today. The fact that most chemical, biological, and radiological agents cause skin-related symptoms, and that the skin symptoms are observed at a relatively early stage of the condition, leads to the conclusion that dermatologists could be the first point of contact for potential victims of these agents. It is highly important that first responders are able to recognize symptoms caused by these agents early and react quickly. Therefore, dermatologists do have a responsibility to take on a role in dealing with chemical, biological, and radiological attacks, and pre-equip themselves with professional knowledge in this field. Among the various types of chemical agents, typical examples of agents causing skin-related symptoms are blistering agents, which lead to bullae and necrosis on the skin. Biological agents are classified from Category A to C according to their respective risk factors. The most dangerous Category A agents include anthrax, smallpox, plague, tularemia, and viral hemorrhagic fever, all of which are known to show characteristic skin-related symptoms. Upon exposure to a certain level of radiation, radiological agents can also lead to erythema on the skin. In this article, we will discuss various characteristics and up-to-date treatment methods of potential chemical, biological, and radiological agents to help dermatologists advance their knowledge in this field.
Anthrax
;
Biological Factors
;
Blister
;
Erythema
;
Hemorrhagic Fevers, Viral
;
Necrosis
;
Plague
;
Risk Factors
;
Skin
;
Smallpox
;
Terrorism
;
Tularemia
;
Weapons
6.To Discern the Medical Thoughts of Heo Joon, the Best Physician in Korean History: An Analysis of Disease Experiences and Treatment Cases in the Treasured Mirror of Eastern Medicine.
Korean Journal of Medical History 2015;24(3):581-620
Heo Joon is one of the best-known physicians of the Chosun Dynasty, the last imperial dynasty (1392~1910) of Korea. He had served King Seonjo during his practice, and has produced many publications on medicine. Then, how did he actually treat the patients? So far, other than the case when he treated Gwanghaegun's smallpox, it is not clearly known how and when he attended and treated the ill. In his most famous book, the Treasured Mirror of Eastern Medicine (TMEM), he details the physiopathological mechanisms, diagnoses, treatments or prescriptions, and treatment cases, however, it is not clear if they're from his own clinical experiences. Nevertheless, based on the written method, the original information is reconstituted according to its respective editors of the TMEM, a particular case being included may be considered as an agreement and acceptance of an actual treatment executed. This research analyzes what type of medicinal theory that the main writer Heo Joon employed in his real treatments, as well as how he diagnosed and treated diseases. After analyzing the complete series of the TMEM, we found a total of 301 clinical cases. Here, one may wonder, why does the Section of Inner and External Bodily Elements, that deal with diseases and the structure of the body, have far outnumber cases than the Section of Miscellaneous Disorders? Why does the TMEM introduce the various types of disease experiences and treatment cases, medical cases, simple treatments, nurturing life, materia medica, and also include supernatural phenomena? Why does the TMEM include the experiences and cases from the book published in the Song, Jin, Yuan dynasty of China, moreover in the Ming Dynasty of its time. These questions can be answered to the extent that Heo Joon and the others who participated in completing the book sought to justify the new clinical medicine practices, and because it had to be acceptable to the Confucius beliefs which dominated the society, and also because the book came to light in a time when tensions between the pre-existing Chosun medicine and the newly introduced Chinese medicine were evident. Among the clinical cases in the TMEM, there are only 41 cases that can be considered as Medical Cases which include the pathology and treatment mechanism. After analyzing these mechanisms, we were able to discover that they cover not only the theories of the 4 great physicians of Jin-Yuan Dynasty, but also the theories of the Danxi's Medical Current, a big trend in the Early Ming Dynasty, and some of the most recent clinical cases that had been just reported at the time. However, Heo Joon did not lean towards a particular theory of medicine; rather, he insisted on establishing a classical medicine based on the traditional medicinal scriptures such as the Yellow Emperor's Inner Canon or Shennong's Classic of Materia Medica, and had created his own Body-Viscera medicine, as Shin Dongwon's recent research. Moreover, he successfully secured his own right to be a clinical physician by customizing the amount of medication in prescriptions for the people of Chosun. Heo Joon was one of the chief physicians for the Royal Family of the Chosun Dynasty. Despite the tendency of traditional medicine to lean towards Taoism or Fangshu, for him the most important thing was the actual treatment of diseases. As a result, Heo Joon successfully treated smallpox by utilizing traditional medicinal methods, by breaking the taboo of not using medication on such diseases, as well as he was able to treat an unknown disease, scarlet fever, by discovering the pathological mechanism of the illness. Also he made bold decisions on altering existing prescriptions to treat diseases more efficiently. The TMEM consists of not only justified methods that integrate the different and scattered medicinal and clinical practices, which many insisted their originality, but also was backed with Heo Joon's such credible and endeavored clinical medicine.
Asian Continental Ancestry Group
;
China
;
Clinical Medicine
;
Diagnosis
;
Humans
;
Korea
;
Materia Medica
;
Medicine, Traditional
;
Music
;
Pathology
;
Prescriptions
;
Religious Philosophies
;
Scarlet Fever
;
Smallpox
;
Taboo
7.Pneumococcal Vaccine-induced Erythema Nodosum: A Case Report.
Ye Seul KIM ; Kyung O KIM ; Ji Hyeon OH ; Sung Yul LEE ; Sang Hoon LEE ; Young Lip PARK
Korean Journal of Dermatology 2015;53(8):643-646
Erythema nodosum is considered to be a hypersensitivity reaction to various conditions. Vaccination-related erythema nodosum is uncommon but cases associated with hepatitis B virus, human papillomavirus, tetanus, diphtheria and pertussis, rabies, smallpox, typhoid and cholera, and Bacille-Calmette-Guerin vaccinations have beenreported. A 33-year-old Korean woman presented with a 3-day history of painful erythematous plaques on both lower legs and knees. Prior to the development of the skin rash, she had received the pneumococcal polysaccharide conjugate vaccine Prevenar13(R). Histological examination of the left lower leg lesion revealed septal panniculitis without vasculitis. To the best of our knowledge, erythema nodosum caused by pneumococcal vaccination has not previously been reported. It is important for clinicians to be aware of this rare, yet potential, adverse effect to the pneumococcal vaccine.
Adult
;
Cholera
;
Diphtheria
;
Erythema Nodosum*
;
Erythema*
;
Exanthema
;
Female
;
Hepatitis B virus
;
Humans
;
Hypersensitivity
;
Knee
;
Leg
;
Panniculitis
;
Rabies
;
Smallpox
;
Tetanus
;
Typhoid Fever
;
Vaccination
;
Vasculitis
;
Whooping Cough
8.Immune control strategies for vaccinia virus-related laboratory-acquired infections.
Qiang WEI ; Meng Nan JIANG ; Jun HAN ; Zi Jun WANG
Biomedical and Environmental Sciences 2014;27(2):142-146
While presenting biological characteristics of vaccinia virus and laboratory-acquired infections during related research processes, this paper focuses on benefits and risks of vaccinia virus immunization in relation to laboratory-acquired infections, describes characteristics and the adaptation of vaccinia virus vaccine, analyses the role vaccinia virus immunization plays in the prevention and control of laboratory-acquired infections, and finally proposes solutions and countermeasures to further promote and implement immune control strategies. The problem related to immune strategy and laboratory- acquired infections which is being raised, analyzed and explored plays an active and instructive role in vaccinia virus related researches and laboratory- acquired infections, and also helps to recommend and develop relevant immune strategy for future vaccine control of such infections.
Contraindications
;
Humans
;
Smallpox Vaccine
;
adverse effects
;
Vaccination
;
standards
;
Vaccinia
;
immunology
;
prevention & control
;
Vaccinia virus
;
immunology
9.Current status of registry of vaccine clinical trials conducted by Korean investigators in ClinicalTrials.gov, database of US National Institutes of Health.
Jahyang CHO ; Bo Bae KIM ; Chong Woo BAE ; Sung Ho CHA
Clinical and Experimental Vaccine Research 2013;2(1):46-52
PURPOSE: PubMed is not only includes international medical journals but also has a registration site for the ongoing clinical trials, such as ClinicalTrials.gov, under the supervision of US National Institutes of Health. We analyzed current status of vaccine clinical trials conducted by Korean investigators in database of ClinicalTrial.gov. MATERIALS AND METHODS: As of October 2012, there are total of 72 trials found on registry of vaccine clinical trials conducted by Korean investigators in database of ClinicalTrial.gov. These trials were analyzed and classified by conditions of vaccine clinical trials, biologicals or drugs used in vaccine clinical trials, status of proceeding research, and list of sponsor and collaborators. RESULTS: Total 72 trials of vaccine clinical trials conducted by Korean investigators are classified by groups of infection (64 trials), cancer (4 trials), and others (4 trials). Infections group shown are as follows: poliomyelitis, pertussis, diphtheria, tetanus, and Haemophilus influenzae type b (10), influenza (9), human papillomavirus infection (8), pneumococcal vaccine (6), herpes zoster (4), smallpox (4), hepatitis B (4), etc. One trial of each in lung cancer, breast cancer, prostate cancer, and colorectal cancer are shown in cancer group. One trial of each in Crohn's disease, ulcerative colitis, renal failure, and rheumatoid arthritis are shown in other group. CONCLUSION: Vaccine clinical trials conducted by Korean investigators in ClinicalTrial.gov reflects the current status of Korean research on vaccine clinical trials at the international level and can indicate research progress. It is hoped that this aids the development of future vaccine clinical trials in Korea.
Arthritis, Rheumatoid
;
Breast Neoplasms
;
Colitis, Ulcerative
;
Colorectal Neoplasms
;
Crohn Disease
;
Diphtheria
;
Haemophilus influenzae type b
;
Hepatitis B
;
Herpes Zoster
;
Humans
;
Influenza, Human
;
Korea
;
Lung Neoplasms
;
National Institutes of Health (U.S.)
;
Organization and Administration
;
Papillomavirus Infections
;
Poliomyelitis
;
Prostatic Neoplasms
;
Renal Insufficiency
;
Research Personnel
;
Smallpox
;
Tetanus
;
Vaccines
;
Whooping Cough
10.Vaccines today, vaccines tomorrow: a perspective.
Clinical and Experimental Vaccine Research 2013;2(1):4-7
Vaccines are considered as one of the major contributions of the 20th century and one of the most cost effective public health interventions. The International Vaccine Institute has as a mission to discover, develop and deliver new and improved vaccines against infectious diseases that affects developing nations. If Louis Pasteur is known across the globe, vaccinologists like Maurice Hilleman, Jonas Salk and Charles Merieux are known among experts only despite their contribution to global health. Thanks to a vaccine, smallpox has been eradicated, polio has nearly disappeared, Haemophilus influenzae B, measles and more recently meningitis A are controlled in many countries. While a malaria vaccine is undergoing phase 3, International Vaccine Institute, in collaboration with an Indian manufacturer has brought an oral inactivated cholera vaccine to pre-qualification. The field of vaccinology has undergone major changes thanks to philanthropists such as Bill and Melinda Gates, initiatives like the Decade of Vaccines and public private partnerships. Current researches on vaccines have more challenging targets like the dengue viruses, malaria, human immunodeficiency virus, the respiratory syncytial virus and nosocomial diseases. Exciting research is taking place on new adjuvants, nanoparticles, virus like particles and new route of administration. An overcrowded infant immunization program, anti-vaccine groups, immunizing a growing number of elderlies and delivering vaccines to difficult places are among challenges faced by vaccinologists and global health experts.
Cholera
;
Communicable Diseases
;
Cooperative Behavior
;
Dengue Virus
;
Developing Countries
;
Haemophilus influenzae
;
HIV
;
Humans
;
Hypogonadism
;
Immunization Programs
;
Infant
;
Malaria
;
Measles
;
Meningitis
;
Missions and Missionaries
;
Mitochondrial Diseases
;
Nanoparticles
;
Ophthalmoplegia
;
Poliomyelitis
;
Public Health
;
Public-Private Sector Partnerships
;
Respiratory Syncytial Viruses
;
Smallpox Vaccine
;
Vaccines
;
Viruses

Result Analysis
Print
Save
E-mail